Divis Laboratories Ltd | DIVI - Ordinary Share Capital


Divis Laboratories Ltd reported INR265.47M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Aurobindo Pharma INR 580.8M 0 Mar/2026
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Lupin INR 456.76M 456.44M Sep/2025
Moderna USD 391M 2M Sep/2025
Organon & Co USD 262.65M 2.33M Mar/2026
Revvity USD 111.63M 174K Jun/2026
Tectonic Therapeutic USD 18.83M 92.19K Mar/2026
Tilray USD 116.52M 5.01M Sep/2025
Viatris USD 1.16B 5.27M Mar/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026